{'output': [['Celgene Corporation', 'COMP', 'Host', 'Conference Call', 'EVENT'], ['Celgene Corporation', 'COMP', 'Discuss', 'Fourth Quarter and Full-Year 2017 Financial and Operational Results', 'EVENT'], ['Celgene Corporation', 'COMP', 'Operate_In', 'Summit, New Jersey', 'GPE'], ['Celgene Corporation', 'COMP', 'Engaged', 'Discovery, Development and Commercialization of Innovative Therapies', 'SECTOR'], ['Celgene Corporation', 'COMP', 'Engaged', 'Protein Homeostasis, Immuno-Oncology, Epigenetics, Immunology and Neuro-Inflammation', 'SECTOR'], ['Patrick E. Flanigan III', 'PERSON', 'Corporate VP, Investor Relations', 'Role'], ['Brian Gill', 'PERSON', 'VP, Corporate Communications', 'Role']]}